At this year’s Annual General Meeting, the shareholders of Gerresheimer endorsed the Company’s current course and approved all proposed resolutions by a majority vote.
In accordance with the Company’s proposal, the discharge of the Supervisory Board and the discharge of former Executive Board members Dietmar Siemssen, Dr. Lukas Burkhardt, and Dr. Bernd Metzner were deferred. Investigations and assessments regarding breaches of duty and potential claims for damages are still ongoing. Uwe Röhrhoff, Wolf Lehmann and Achim Schalk were granted discharge for their service on the Executive Board during financial year 2025.
Gerresheimer had thoroughly addressed errors in revenue recognition and accounting through two internal assessments and reflected these in the 2025 annual and consolidated financial statements. With the implementation of the gto transformation program and the sale of the two business units, Centor and Primary Packaging Plastics, Gerresheimer is expected to significantly improve its earnings and financial situation going forward.
“Today, Gerresheimer once again has a clear strategic vision,” said Achim Schalk, a member of the Management Board. “We have set the course for debt reduction and comprehensive refinancing. We are implementing a clear portfolio strategy with an even stronger focus on high-quality drug delivery devices, medical devices and primary packaging for injectable drugs. In doing so, we have laid the groundwork for Gerresheimer to return to profitable growth in the future.”
Markus Sieger is the new Chairman of the Supervisory Board
The tenure of Dr. Axel Herberg, Andrea Abt, and Dr. Annette G. Köhler ended as scheduled at the close of the Annual General Meeting. They did not run for reelection. Rainer Beaujean, Markus Sieger, and Eva van Pelt were newly elected to the Supervisory Board. Klaus Röhrig, who had been appointed by a court order as a member of the Supervisory Board in 2025, was reelected. At the subsequent organisational meeting, the Supervisory Board elected Markus Sieger as its new Chairman.
Clear majorities for all proposed resolutions
With 41.59 percent of the share capital represented, the Annual General Meeting approved all agenda items by a majority vote. The compensation report and the compensation system were approved. KPMG AG Wirtschaftsprüfungsgesellschaft, Düsseldorf, was elected as the independent auditor for the financial year 2026.
The detailed voting results of the Annual General Meeting and the Management Board’s report can be found here.
The Annual Report can be found here.